Profil
Dr. Tomas Odergren is a Chief Medical Officer at BioArctic AB and a Chairman at NovaSAID AB. Dr. Odergren was previously employed as a Vice President-Clinical Development by Karolinska Development AB, a Principal by AstraZeneca GmbH, and a Non-Executive Director by BioChromix Pharma AB. He also served on the board at Athera Biotechnologies AB, Forendo Pharma Oy, Modus Therapeutics AB, Modus Therapeutics Holding AB and Umecrine Cognition AB. He received his doctorate degree from Karolinska Institutet.
Aktive Positionen von Tomas Odergren
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOARCTIC AB | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2019 |
NovaSAID AB
NovaSAID AB Pharmaceuticals: MajorHealth Technology Develops treatments for inflammation and pain in conditions such as rheumatoid arthritis | Vorsitzender | - |
Ehemalige bekannte Positionen von Tomas Odergren
| Unternehmen | Position | Ende |
|---|---|---|
| KDVENTURES AB | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2014 |
AstraZeneca GmbH
AstraZeneca GmbH Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical drugs | Corporate Officer/Principal | 12.10.2012 |
Umecrine Cognition AB
Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Develops drug for neurological disorders of the brain | Direktor/Vorstandsmitglied | - |
Forendo Pharma Oy
Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage drug company that develops novel treatments in women’s health | Direktor/Vorstandsmitglied | - |
Modus Therapeutics AB
Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drug for the treatment of severe malaria and sickle cell disease | Direktor/Vorstandsmitglied | - |
Ausbildung von Tomas Odergren
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Athera Biotechnologies AB
Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Provides anti-inflammatory biological candidate drugs | Health Technology |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioArctic AB
BioArctic AB Pharmaceuticals: MajorHealth Technology Develops drugs for patients with disorders of the central nervous systems | Health Technology |
AstraZeneca GmbH
AstraZeneca GmbH Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical drugs | Health Technology |
BioChromix Pharma AB
BioChromix Pharma AB Miscellaneous Commercial ServicesCommercial Services Provides Alzheimer disease research services | Commercial Services |
Umecrine Cognition AB
Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Develops drug for neurological disorders of the brain | Health Technology |
NovaSAID AB
NovaSAID AB Pharmaceuticals: MajorHealth Technology Develops treatments for inflammation and pain in conditions such as rheumatoid arthritis | Health Technology |
Karolinska Development AB
Karolinska Development AB Financial ConglomeratesFinance Operates as a life sciences investment company | Finance |
Modus Therapeutics AB
Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drug for the treatment of severe malaria and sickle cell disease | Health Technology |
Modus Therapeutics Holding AB
Modus Therapeutics Holding AB BiotechnologyHealth Technology Develops sevuparin to treat people suffering from sickle cell disease | Health Technology |
Forendo Pharma Oy
Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage drug company that develops novel treatments in women’s health | Health Technology |
















